UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest reported): July 26, 2001
HEALTHNET INTERNATIONAL INC.
(Exact name of registrant as specified in its chapter)
Colorado 000-26553 98-0206627
(State or other jurisdiction (Commission (IRS Employer
of incorporation File Number) Identification No.)
100-1255 West Pender Street
Vancouver, British Columbia
Canada V6E 2V1
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (604) 678-9101
301 - 1201 West Pender Street
Vancouver, British Columbia
V6E 2V2
(Former name or former address, if changed since last report)
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.
On June 1, 2001, Healthnet International, Inc. (the "Company") engaged Grant
Thornton LLP, Chartered Accountants of Vancouver, British Columbia ("Grant
Thornton") as its principal independent accountants to audit the Company's
financial statements. On the same date, the Company advised Ernst & Young LLP
Chartered Accountants of Vancouver, British Columbia ("Ernst & Young") that it
was dismissed as the Company's independent accountant. The Company's Board of
Directors approved the engagement of Grant Thornton and the dismissal of Ernst &
Young on June 1, 2001.
Ernst & Young's reports on the financial statements of the Company during the
Company's two most recent fiscal years and the subsequent interim period
preceding the dismissal of Ernst & Young have not contained an adverse opinion
or a disclaimer of opinion and were not qualified or modified as to uncertainty,
audit scope or accounting principles.
There have been no disagreements during the Company's two most recent fiscal
years and the subsequent interim period preceding the dismissal of Ernst & Young
between the Company and Ernst & Young an any matter of accounting principles or
practices, financial statement disclosure or auditing scope or procedure, which,
if not resolved to Ernst & Young's satisfaction, would have caused Ernst & Young
to make reference to the subject matter of such disagreements in connection with
its reports.
In connection with the filing of this Form 8-K, Ernst & Young was provided with
a copy of this disclosure and was requested by the Company to furnish to the
Company a letter addressed to the SEC stating whether Ernst & Young agrees with
the above statements. A copy of Ernst & Young's letter to the SEC will be filed
with the SEC within two business days after its receipt by the Company.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: July 26, 2001
------------- ----------------------------------------
Healthnet International Inc.
/s/ Grant R. Johnson
----------------------------------------
Grant R. Johnson
President